A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Constellation Pharmaceuticals
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Constellation Pharmaceuticals
ClinicalTrials.gov Identifier:
First received: September 10, 2013
Last updated: July 27, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)